Study On Growth Evaluation Of Listed Companies In Medical Industry

Growth is the very core of a listed company, the life in the security market, the motive force of the sustained development of national economy, an important indicator which measures the management capabilities and the development prospect of the listed company. In a growing process, listed companies' growth is specially represented by some tendencies such as being benefit from industrial policy, bright growing prospect, raising sales, extending enterprise scale, increasing economic profits. With diversified core competence, each subsidiary medical industry are in different growing backgrounds though the growing prospect of medical industry is bright. In this situation, investors still hope to share the economic growth in medical industry and to obtain stable investing profits. For this reason, it is of great importance to evaluate listed companies' growth. Studying on listed companies' growth has great practical significance.Based on data of listed companies in medical industry which can be openly obtained, guided by modern economic theories as well as modern statistical theories and methods, taking in the latest domestic and abroad achievements in this field, and adopting the methods of normative and positive analysis, this research tries to seek out the internal relationship between the growth of listed companies and its influential elements, systematically analyzes the conditions and the characteristics of listed companies in medical industry and deeply explores the action mechanism of some factors which influence the companies' growing capacity. Through model construction of listed companies growth evaluation and prediction of their growing level, this research proposes some suggestions to promote listed companies' growth and to work out profitable investment strategies.Studies have shown that, as a whole, listed companies in medical industry have good growth propensity and bright growing prospect. But each subsidiary medical industry has different growing efficiency. Besides, three factors include low centralization, week core competency and low research capability, turn into keyreasons that hinder the growth of medical industry companies. So the following measures should be taken to strengthen growth potential of medical listed companies: using the experiences of other listed companies to increase the growing potential; enhancing industrial centralization by asset reorganization and resource integration; achieving industrial structure optimization through technology progress. Meanwhile, the following elements also can be taken in to consideration for investors to optimize their investment strategies: paying attention to different growing potential in subsidiary medical industry with discernment of distinct subsidiary medical industrial policies; observing products competitiveness and research-and-development (R&D) capability of the listed companies; analyzing financial ratios and indications especially enterprises' investment rate-of-return, operation efficiency, cash flow and financing structure.